Study on assessment of quality of life and depression in patients of vitiligo

Kota, Rahulkrishna S; Vora, Rita V; Varma, Jagdish; Kota, Suresh K.; Patel, Trusha; Ganjiwale, Jaishree

doi:10.4103/idoj.idoj_14_18

Cited by 32 publications

(11 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Higher quimp in patients with darker skin types than in those with fair skin was also reported 42 . Mean DLQI scores of adult vitiligo patients from studies performed in 21 different countries are presented in Figure 2 44–83 . Most studies demonstrated a moderate or small effect on patient's lives score according to the DLQI banding descriptors.…”

Section: Resultsmentioning

confidence: 86%

“…In another study, HRQoL was significantly worse in adolescents 41 . Young patients showed higher impairment of QoL and also higher levels of depression 44 . Dermatology‐specific QoL was more impaired in those who were younger than 30 years old than in older subjects 92 .…”

Section: Resultsmentioning

confidence: 91%

“…41 Young patients showed higher impairment of QoL and also higher levels of depression. 44 Dermatology-specific QoL was more impaired in those who were younger than 30 years old than in older subjects. 92 The mean DLQI score was higher in the 30-59 years old group than in the over 60 years old group.…”

Section: Qol In Vitiligo Patients Of Different Agesmentioning

confidence: 90%

“…In several VIS‐22 items, vitiligo is not mentioned and (as in case of the VitiQoL) this may lead to a misunderstanding that the questions are not limited of vitiligo. VIS‐22 was used in four different studies including studies from China and Nepal 44,65,92,125 …”

Section: Discussionmentioning

confidence: 99%

“…VIS-22 was used in four different studies including studies from China and Nepal. 44,65,92,125 The Vitiligo Life Quality Index (VLQI) 29 has a 1-week recall period and so may reflect HRQoL changes after short periods of time, such as following treatment. In contrast to other vitiligo-specific instruments, the VLQI contains an item on pain, irritation or itching due to vitiligo.…”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts

Chernyshov

Aragonés

Manolache³

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 86%

Section: Resultsmentioning

confidence: 91%

Section: Qol In Vitiligo Patients Of Different Agesmentioning

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts

Chernyshov

Aragonés

Manolache³

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Psychosocial impact of vitiligo in patients with skin of color

Mehta

Gupta

2022

Dermatological Reviews

View full text Add to dashboard Cite

Vitiligo exerts a significant negative effect on patients' quality of life. Patients with skin of colour have a more negative attitude towards vitiligo than those with fairer skin. Many myths and misconceptions about vitiligo are prevalent in certain societies in South-east Asia and the middle east. Confusion with leprosy further adds to the stigma. Vitiligo impacts several spheres of life due to the cosmetic disfigurement as well as the prevailing socio-cultural factors. Patients with vitiligo suffer from low self-esteem, and often face discrimination, and difficulties in social life and relationships. Quality-of-life measures such as Dermatology Life Quality Index and Vitiligo Impact Scale-22 indicate that vitiligo has a moderate-to-large effect on patients' life. Psychiatric comorbidities such as anxiety and depression are more prevalent among patients with vitiligo as compared to general population. The psychosocial burden of vitiligo should be evaluated separately from the clinical severity separately because it may not correlate with the extent of depigmentation, and may not improve in proportion to the repigmentation. Apart from the treatment of vitiligo patches, patients may benefit from measures specifically aimed at reducing the psychosocial distress.

show abstract

Quality of life, disease burden and healthcare need of patients with vitiligo

Augustin,

Gewiss,

Ben-Anaya

et al. 2024

Dermatologie

View full text Add to dashboard Cite

Zusammenfassung Hintergrund Vitiligo ist mit einer Prävalenz von 0,5–2,0 % eine der weltweit häufigsten Hauterkrankungen mit einem Verlust des Pigments. Die Hauterkrankung hat einen entstellenden, oft stigmatisierenden Charakter und ist oft mit psychosozialen Belastungen assoziiert. Zielsetzung Es erfolgt eine Übersicht über die psychosoziale Beeinträchtigung, Krankheitslast und den resultierenden Versorgungsbedarf von Patienten mit Vitiligo. Material und Methoden Es handelt sich um eine narrative Übersichtsarbeit auf der Grundlage einer Literaturrecherche in PubMed für die Jahre 1996 bis 2022 zu den Themen Krankheitslast, Lebensqualität und Stigmatisierung. Ergebnisse Die Recherche ergab für den Suchzeitraum 175 relevante Originalarbeiten inklusive klinischer Studien, Metaanalysen und systematischer Übersichtsarbeiten (n = 65). Dabei dokumentiert eine Vielzahl an Studien, dass Vitiligo bei den Betroffenen mit erheblichen psychosozialen Belastungen und relevanten Einbußen an Lebensqualität einhergeht. Problembereiche betreffen insbesondere Stigmatisierung, sexuelle Funktionsstörungen, Angst, vermindertes Selbstwertgefühl und Probleme im Beruf. Das beobachtete erhöhte Ausmaß von Angst und Depressionen korreliert mit der Schwere und Aktivität der Vitiligo. Oft trägt auch Komorbidität zur weiteren Krankheitslast bei. Diese Faktoren determinieren bei einem relevanten Teil der Betroffenen einen hohen Versorgungsbedarf. Diskussion Die Vitiligo stellt nicht in erster Linie ein kosmetisches Problem dar, sondern eine behandlungsbedürftige Erkrankung im Sinne der Definition der Weltgesundheitsorganisation von Gesundheit als körperliches, geistiges und soziales Wohlbefinden. Die Nutzen von Behandlungsoptionen sind an ihren Effekten auf patientenberichtete Endpunkte zu messen. Graphic abstract

show abstract

Study on assessment of quality of life and depression in patients of vitiligo

Cited by 32 publications

References 18 publications

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts

Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts

Psychosocial impact of vitiligo in patients with skin of color

Quality of life, disease burden and healthcare need of patients with vitiligo

Contact Info

Product

Resources

About